Flexmap 3D

FDA 510(k) K133302 · Luminex Corp.

Substantially Equivalent

510(k) numberK133302

Submission

Device name
Flexmap 3D
Applicant
Luminex Corp.
Austin, TX, US
Received
October 25, 2013
Decision date
January 10, 2014
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) statement available from FDA

Official FDA 510(k) record

Device classification

Product code
NSU – Instrumentation For Clinical Multiplex Test Systems
Device class
Class II (moderate risk)
Regulation
21 CFR 862.2570
Specialty
Clinical Chemistry

Instrumentation for clinical multiplex test systems is a device that is intended to measure and sort multiple signals generated by an assay from a clinical sample. The generated signals from multiple probes or other ligands may be measured by fluorescence, luminescence, or other physical or chemical properties. The device may integrate scanning, reagent handling, hybridization, washing…

Other 510(k)s with product code NSU

510(k)DeviceApplicantDecision
K163652ePlex InstrumentNSU · Traditional Genmark Diagnostics, Incorporated06/09/2017SE
K143178FilmArray 2.0 SystemNSU · Traditional Biofire Diagnostics, LLC01/30/2015SE
K133849Vantera Clinical AnalyzerNSU · Special Liposcience10/22/2014SE
K141220Applied Biosystems 7500 Fast DX Real-Time PCR Instrument with SDS SoftwareNSU · Special Thermo Fisher Scientific (Life Technologies Holdin05/22/2014SE
K121399Luminex Flexmap 3D Instrument System, Luminex Xponent 4.0 Spi Software, Flexmap 3D IVD…NSU · Traditional Luminex Corp.01/09/2013SE
K110786Esensor Warfarin Sensitivity Saliva TestNSU · Traditional GenMark Diagnostics, Inc.12/02/2011SE
K093128Illumina Beadxpress SystemNSU · Traditional Illumina, Inc.04/28/2010SE
K082562Applied Biosystems 7500 Fast DXNSU · Traditional Applied Biosystems, Inc.09/30/2008SE
K080995Modification to Affymetrix Genechip Microarray Instrumentation SystemNSU · Traditional Affymetrix, Inc.07/30/2008SE
K073506Luminex LX 100/200 InstrumentNSU · Traditional Luminex Corp.03/07/2008SE

More from Luminex Corp.

510(k)DeviceDecision
K253722LIAISON PLEX Gastrointestinal Flex AssayPCH · Traditional 05/19/2026SE
K243490LIAISON PLEX Gram-Positive Blood Culture AssayPAM · Traditional 06/06/2025SE
K243013LIAISON PLEX Gram-Negative Blood Culture AssayPEN · Traditional 04/18/2025SE
K240627LIAISON PLEX Yeast Blood Culture AssayPEO · Traditional 06/04/2024SE
K233410LIAISON PLEX Respiratory Flex AssayQOF · Traditional 03/01/2024SE
K191742ARIES MRSA AssayNQX · Traditional 09/25/2019SE
K172402ARIES Group A Strep Assay, ARIES Group A Strep Assay Protocol File KitPGX · Traditional 10/30/2017SE
K171441ARIES C. difficile Assay Complete Kit, ARIES C. difficile Assay Protocol File Kit, ARIES…OZN · Traditional 07/21/2017SE
K163626ARIES Bordetella Assay; ARIES Bordetella Assay Protocol File KitOZZ · Traditional 05/02/2017SE
K162772ARIES GBS AssayNJR · Traditional 12/23/2016SE

Questions and answers

When was Flexmap 3D cleared by the FDA?

Flexmap 3D (K133302) received a 510(k) decision of Substantially Equivalent on January 10, 2014, 77 days after the submission was received.

What is the product code of K133302?

The FDA product code is NSU – Instrumentation For Clinical Multiplex Test Systems, a Class II (moderate risk) device regulated under 21 CFR 862.2570.